Vasudha Pharma Chem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NORTRIPTYLINE HYDROCHLORIDE USP, with a corresponding US DMF Number 31974.
Remarkably, this DMF maintains an Active status since its submission on September 08, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 20, 2019, and payment made on January 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II